Clinical utility and research frontiers of neuroimaging in movement disorders

Flavio Nobili, Eric Westman, Rosalie V. Kogan, Joana B. Pereira, Federico Massa, Matteo Grazzini, Sanne K. Meles, Klaus L. Leenders

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Neuroimaging in Parkinson's disease (PD) and other primary Parkinsonian disorders has been increasingly used in the routine clinical work in the last years. The paradigm has changed from an "exclusionary" use, i.e., to rule out causes of secondary Parkinsonism, to an "inclusionary" one, i.e., finding image and network characteristics allowing to identify a specific disease. This is allowed by analyses spanning from the commonly used visual analysis to the most sophisticated postprocessing leading to the identification of covariance patterns both in morphological and functional neuroimaging. However, paralleling the advancement in covariance and connectivity analyses, the issues of standardization and harmonization of data acquisition, and image reconstruction and postprocessing among centers are emerging in the scientific community. Also, the building of scientific evidence still suffers from the lack of large, formal studies and relies on relatively small cohort studies from one or few centers. Joint actions to face these issues are now ongoing in Europe, supported by specific programs, such as the Joint Programming on Neurodegenerative Diseases (JPND). In the present review, some of the most recent and relevant achievements in the field of diffusion tensor magnetic resonance imaging (MRI), functional MRI, fludeoxyglucose-positron-emission tomography, dopamine transporter single-photon emission computed tomography and non-dopaminergic imaging in PD and primary Parkinsonisms are reported.

Original languageEnglish
Pages (from-to)372-385
Number of pages14
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume61
Issue number4
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Movement Disorders
Neuroimaging
Parkinson Disease
Secondary Parkinson Disease
Dopamine Plasma Membrane Transport Proteins
Functional Neuroimaging
Diffusion Magnetic Resonance Imaging
Computer-Assisted Image Processing
Parkinsonian Disorders
Single-Photon Emission-Computed Tomography
Research
Neurodegenerative Diseases
Positron-Emission Tomography
Cohort Studies
Magnetic Resonance Imaging

Keywords

  • Emission-computed
  • Fluorodeoxyglucose F18
  • Magnetic resonance imaging
  • Parkinson disease
  • Parkinsonian disorders
  • Positron-emission tomography
  • Single-photon
  • Tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Clinical utility and research frontiers of neuroimaging in movement disorders. / Nobili, Flavio; Westman, Eric; Kogan, Rosalie V.; Pereira, Joana B.; Massa, Federico; Grazzini, Matteo; Meles, Sanne K.; Leenders, Klaus L.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, No. 4, 01.12.2017, p. 372-385.

Research output: Contribution to journalReview article

Nobili, Flavio ; Westman, Eric ; Kogan, Rosalie V. ; Pereira, Joana B. ; Massa, Federico ; Grazzini, Matteo ; Meles, Sanne K. ; Leenders, Klaus L. / Clinical utility and research frontiers of neuroimaging in movement disorders. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2017 ; Vol. 61, No. 4. pp. 372-385.
@article{e383f5385240488aaf136bdbff7fd3c3,
title = "Clinical utility and research frontiers of neuroimaging in movement disorders",
abstract = "Neuroimaging in Parkinson's disease (PD) and other primary Parkinsonian disorders has been increasingly used in the routine clinical work in the last years. The paradigm has changed from an {"}exclusionary{"} use, i.e., to rule out causes of secondary Parkinsonism, to an {"}inclusionary{"} one, i.e., finding image and network characteristics allowing to identify a specific disease. This is allowed by analyses spanning from the commonly used visual analysis to the most sophisticated postprocessing leading to the identification of covariance patterns both in morphological and functional neuroimaging. However, paralleling the advancement in covariance and connectivity analyses, the issues of standardization and harmonization of data acquisition, and image reconstruction and postprocessing among centers are emerging in the scientific community. Also, the building of scientific evidence still suffers from the lack of large, formal studies and relies on relatively small cohort studies from one or few centers. Joint actions to face these issues are now ongoing in Europe, supported by specific programs, such as the Joint Programming on Neurodegenerative Diseases (JPND). In the present review, some of the most recent and relevant achievements in the field of diffusion tensor magnetic resonance imaging (MRI), functional MRI, fludeoxyglucose-positron-emission tomography, dopamine transporter single-photon emission computed tomography and non-dopaminergic imaging in PD and primary Parkinsonisms are reported.",
keywords = "Emission-computed, Fluorodeoxyglucose F18, Magnetic resonance imaging, Parkinson disease, Parkinsonian disorders, Positron-emission tomography, Single-photon, Tomography",
author = "Flavio Nobili and Eric Westman and Kogan, {Rosalie V.} and Pereira, {Joana B.} and Federico Massa and Matteo Grazzini and Meles, {Sanne K.} and Leenders, {Klaus L.}",
year = "2017",
month = "12",
day = "1",
doi = "10.23736/S1824-4785.17.03018-7",
language = "English",
volume = "61",
pages = "372--385",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Clinical utility and research frontiers of neuroimaging in movement disorders

AU - Nobili, Flavio

AU - Westman, Eric

AU - Kogan, Rosalie V.

AU - Pereira, Joana B.

AU - Massa, Federico

AU - Grazzini, Matteo

AU - Meles, Sanne K.

AU - Leenders, Klaus L.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Neuroimaging in Parkinson's disease (PD) and other primary Parkinsonian disorders has been increasingly used in the routine clinical work in the last years. The paradigm has changed from an "exclusionary" use, i.e., to rule out causes of secondary Parkinsonism, to an "inclusionary" one, i.e., finding image and network characteristics allowing to identify a specific disease. This is allowed by analyses spanning from the commonly used visual analysis to the most sophisticated postprocessing leading to the identification of covariance patterns both in morphological and functional neuroimaging. However, paralleling the advancement in covariance and connectivity analyses, the issues of standardization and harmonization of data acquisition, and image reconstruction and postprocessing among centers are emerging in the scientific community. Also, the building of scientific evidence still suffers from the lack of large, formal studies and relies on relatively small cohort studies from one or few centers. Joint actions to face these issues are now ongoing in Europe, supported by specific programs, such as the Joint Programming on Neurodegenerative Diseases (JPND). In the present review, some of the most recent and relevant achievements in the field of diffusion tensor magnetic resonance imaging (MRI), functional MRI, fludeoxyglucose-positron-emission tomography, dopamine transporter single-photon emission computed tomography and non-dopaminergic imaging in PD and primary Parkinsonisms are reported.

AB - Neuroimaging in Parkinson's disease (PD) and other primary Parkinsonian disorders has been increasingly used in the routine clinical work in the last years. The paradigm has changed from an "exclusionary" use, i.e., to rule out causes of secondary Parkinsonism, to an "inclusionary" one, i.e., finding image and network characteristics allowing to identify a specific disease. This is allowed by analyses spanning from the commonly used visual analysis to the most sophisticated postprocessing leading to the identification of covariance patterns both in morphological and functional neuroimaging. However, paralleling the advancement in covariance and connectivity analyses, the issues of standardization and harmonization of data acquisition, and image reconstruction and postprocessing among centers are emerging in the scientific community. Also, the building of scientific evidence still suffers from the lack of large, formal studies and relies on relatively small cohort studies from one or few centers. Joint actions to face these issues are now ongoing in Europe, supported by specific programs, such as the Joint Programming on Neurodegenerative Diseases (JPND). In the present review, some of the most recent and relevant achievements in the field of diffusion tensor magnetic resonance imaging (MRI), functional MRI, fludeoxyglucose-positron-emission tomography, dopamine transporter single-photon emission computed tomography and non-dopaminergic imaging in PD and primary Parkinsonisms are reported.

KW - Emission-computed

KW - Fluorodeoxyglucose F18

KW - Magnetic resonance imaging

KW - Parkinson disease

KW - Parkinsonian disorders

KW - Positron-emission tomography

KW - Single-photon

KW - Tomography

UR - http://www.scopus.com/inward/record.url?scp=85031942264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031942264&partnerID=8YFLogxK

U2 - 10.23736/S1824-4785.17.03018-7

DO - 10.23736/S1824-4785.17.03018-7

M3 - Review article

AN - SCOPUS:85031942264

VL - 61

SP - 372

EP - 385

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 4

ER -